A new combination was shown to mitigate graft-versus-host disease (GVHD) for patients undergoing a hematopoietic stem cell transplant (HSCT).
The number of positive lymph nodes can help guide treatment for locally advanced head and neck cancer, according to a recent study.
Axicabtagene ciloleucel had high response rates in patients with non-Hodgkin lymphoma in a phase 2 study.
"Telenutrition" programs can help high-risk patients who do not otherwise have access to a registered dietician, according to a recent study and program launched at the Carolinas HealthCare System.
Cabometyx combinations showed activity in patients with GU cancers, according to a preliminary clinical study.
David McDermott, M.D. discusses new advances made to treat kidney cancer.
The FDA granted Zykadia a priority review for the frontline treatment of some patients with lung cancer.
Since it is found in the majority of patients with mCRPC, circulating tumor DNA may be able to lead the way to more personalized prostate cancer care.
More people with AML who were treated with Vyxeos were moved to transplant than those treated with a standard chemotherapy regimen, according to recent findings.